Acceleron Pharma Inc Dívida/Patrimônio

Qual é o Dívida/Patrimônio de Acceleron Pharma Inc?

O Dívida/Patrimônio de Acceleron Pharma Inc é 1.10

Qual é a definição de Dívida/Patrimônio?



O índice de endividamento é um índice financeiro que indica a proporção relativa do patrimônio líquido e da dívida usada para financiar os ativos de uma empresa.

The debt to equity ratio is generally calculated by dividing debt by equity. The D/E ratio is also known as risk, gearing or leverage. The two components are often taken from the firm's balance sheet or statement of financial position (so-called book value), but the ratio may also be calculated using market values for both, if the company's debt and equity are publicly traded, or using a combination of book value for debt and market value for equity financially. Preferred stock can be considered part of debt or equity. Attributing preferred shares to one or the other is partially a subjective decision but will also take into account the specific features of the preferred shares. When used to calculate a company's financial leverage, the debt usually includes only the long-term debt.

Dívida/Patrimônio de empresas na Setor Health Care em NASDAQ em comparação com Acceleron Pharma Inc

O que Acceleron Pharma Inc faz?

Acceleron is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapeutics to treat serious and rare diseases. Acceleron's leadership in the understanding of TGF-beta superfamily biology and protein engineering generates innovative compounds that engage the body's ability to regulate cellular growth and repair.

Empresas com dívida/patrimônio semelhantes a Acceleron Pharma Inc